Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. The Company’s operations are structured into three business areas: Anaesthesia, Patient Monitoring & Diagnostics and Emergency Care. The Anaesthesia business area offers a range of products such as resuscitators, face masks and laryngeal masks. The Patient Monitoring & Diagnostics business area comprises single use electrodes for cardiological and neurological examinations. The target groups for these products are hospitals, clinics, ambulance services and sleep labs. The Emergency Care business area offers ventilation bags, neck collars and manikins for first-aid training. The firm markets its products worldwide. The firm operates King Systems Inc, First Water Heathcote Ltd and Invendo Medical GmbH as subsidiaries.
Follow-Up Questions
Who is the CEO of Ambu A/S?
Ms. Britt Meelby Jensen is the Chief Executive Officer of Ambu A/S, joining the firm since 2019.
What is the price performance of AMBBY stock?
The current price of AMBBY is $16.31, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Ambu A/S?
Ambu A/S belongs to Health Care industry and the sector is Health Care
What is Ambu A/S market cap?
Ambu A/S's current market cap is $3.7B
Is Ambu A/S a buy, sell, or hold?
According to wall street analysts, 13 analysts have made analyst ratings for Ambu A/S, including 3 strong buy, 5 buy, 5 hold, 0 sell, and 3 strong sell
